DMPK and non-small cell lung carcinoma: Thus, it is tempting to speculate that up-regulation of DM pathways in H1299IR cells serve as a prognostic biomarker of DM in patients with NSCLC, suggesting that pre-existing NSCLC is a potent inducer of DM leading to a worse prognosis.